Identification of Metabolites From Gut Microbiota in HPV Infection Through Network Pharmacology

10 Apr 20264 min read0 viewsJournal Feed

GIST

by Wenbo Dong, Bai Li, Zhiwei Xu, Qi Wang, Zhihui Hou, Hongling Jia Human papillomavirus (HPV) infection continues to pose a significant global health challenge. Although gut microbial metabolites have been associated with HPV infection, the mechanisms underlying this relationship remain inadequately understood.

A network pharmacology approach was utilized to comprehensively explore the connections between gut microbial metabolites and HPV infection. Using gutMGene, GeneCards, OMIM and other databases, 43 key targets were identified as common elements between gut microbial metabolites and HPV infection.

Protein-protein interaction network analysis further screened 10 core targets, including IL6, AKT1, IL1B, CASP3, NFKB1, EGFR, PPARG, JUN, PTGS2, and TLR4. Gene ontology (GO) enrichment analysis of these 43 key targets indicated their involvement in lipopolysaccharide response, oxidative stress, and inflammatory signaling.

Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of the 10 core targets highlighted the TNF, Toll-like receptor, C-type lectin receptor, and IL-17 signaling pathways as the main enriched pathways. A comprehensive microbiota-metabolite-target-pathway network was constructed, illustrating that these core targets interact with 13 gut microbial metabolites, 97 gut microbes, and 10 key pathways.

Clinical Editorial

The study rationale and design framework

Scope and objective: The investigation aims to elucidate how gut microbial metabolites relate to human papillomavirus (HPV) infection, addressing gaps in understanding the underlying mechanisms.
Methodology base: A network pharmacology approach was employed to map connections among gut microbial metabolites, host targets, and HPV infection, drawing on multiple public resources.

Expanded target discovery and core signaling players

Candidate target identification: Databases such as gutMGene, GeneCards, and OMIM yielded 43 targets that serve as common nodes for gut microbial metabolites and HPV-related processes.
Core target refinement: Protein-protein interaction analysis distilled this set to 10 core targets, namely IL6, AKT1, IL1B, CASP3, NFKB1, EGFR, PPARG, JUN, PTGS2, and TLR4.
Functional context: GO enrichment linked these targets to responses to lipopolysaccharide, oxidative stress, and inflammatory signaling.

Pathway landscape and mechanistic hypotheses

Key pathways highlighted: KEGG analysis emphasized TNF signaling, Toll-like receptor signaling, C-type lectin receptor signaling, and IL-17 signaling as central routes potentially modulated in the context of HPV infection.
Integrated network view: A microbiota-metabolite-target-pathway network connected 13 gut microbial metabolites with 97 gut microbes and 10 principal pathways via the 10 core targets, illustrating plausible routes of influence.

Metabolite candidates and interaction signals

Prominent metabolites: Among the screened compounds, succinate and short-chain fatty acids (acetate, butyrate, propionate) stood out for favorable drug-likeness and safety profiles; succinate emerged as particularly noteworthy.
Molecular interaction: Docking analyses suggested a potential interaction between succinate and the inflammatory mediator IL1B, with a binding energy of −5.66 kcal/mol.

Uncertainty, limitations, and implications for future work

Evidence strength: The findings are based on computational network pharmacology and in silico docking, without experimental validation presented in the source.
Limitations: Specific clinical outcomes, quantitative effect sizes, and in vivo relevance were not reported in the source.